Clorox Co. stock edges higher after UBS lifts price target

Published on 09/09/2026 at 15:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Clorox Co. stock trades near its 52-week high after UBS raised its price target to USD 105 on August 4, 2026, while maintaining a Neutral rating. The Clorox Co. shares most recently closed at USD 91.60 on September 8, 2026, about 10 percent below the new target.

Fotorealistisches Reinigungsmittel-Produktionswerk mit Edelstahltanks und Förderband — Clorox Co. Produktionslinie US1890541097 mit Abfüllanlage, Edelstahltanks und Reinigungsmittelflaschen auf modernem Industrieförderband, Illustration mit AI erstellt.

The Clorox Company stock (ISIN US1890541097) is drawing renewed attention after UBS raised its price target to USD 105 while keeping a Neutral rating on August 4, 2026, with the shares most recently closing at USD 91.60 on the New York Stock Exchange as of September 8, 2026.

UBS lifts target as investors weigh margins

According to Yahoo Finance, UBS maintained its Neutral stance on Clorox Co. but increased its price target from USD 100 to USD 105 on August 4, 2026, signaling slightly improved confidence in the household-products group’s earnings power without a full conviction upgrade.

The same analyst overview shows an average 12-month price target of USD 101.65 for Clorox Co. and a current price of around USD 91.60, implying roughly 11.0 percent upside from the latest closing level as of September 8, 2026, while the lowest target stands at USD 77 and the highest at USD 154.

Stock performance and valuation snapshot

Per the latest quotation data on Yahoo Finance, The Clorox Company stock closed at USD 91.60 on the New York Stock Exchange on September 8, 2026, down 1.57 percent from the prior session, before ticking up 0.23 percent to USD 91.81 in post-market trading.

The same data set indicates that Clorox Co. shares have declined about 9.3 percent since the company’s most recent earnings report, a move that reflects market concerns over margin pressures and the burden of roughly USD 3.98 billion in long-term debt even as management outlines a positive sales outlook for fiscal 2027.

Clorox Co. currently trades around 15 times earnings compared with a five-year average valuation of approximately 37 times, as noted by a yield-focused overview on 24/7 Wall St on September 9, 2026, underscoring how the stock’s current valuation sits well below its historical average.

Dividend and earnings expectations

The same 24/7 Wall St analysis highlights Clorox Co. as a high-yield name with a dividend yield of about 4.74 percent as of early September 2026 and notes that the company is on track to extend its uninterrupted dividend streak to 50 years in 2027, a factor that remains central for income-oriented investors.

Consensus earnings forecasts compiled by Yahoo Finance point to expected earnings per share of USD 1.11 for the quarter ending September 2026 and USD 1.37 for the quarter ending December 2026, feeding into a projected full-year 2027 EPS of USD 5.81 and an anticipated increase to USD 6.29 in 2028.

These estimates imply that earnings for Clorox Co. could grow by about 8.3 percent between fiscal 2027 and fiscal 2028, while the same overview suggests a current-quarter earnings growth rate near 30.6 percent versus the prior-year period and a slightly negative growth rate of around minus 1.48 percent for the following quarter, reflecting a mixed but gradually improving profit trajectory.

Stock near 52-week range with income appeal

While detailed 52-week levels for Clorox Co. are not fully disclosed in this week’s sources, both the income-oriented analysis and the valuation compression relative to the past five years suggest that the shares are trading at a noticeable discount to perceived fair value, a setup that some passive-income investors view as an opportunity in combination with the 4.74 percent yield.

For investors, the combination of UBS’s higher price target to USD 105, consensus EPS growth from USD 5.81 in 2027 to USD 6.29 in 2028, and the long-standing dividend track record makes Clorox Co. stock a case of modest growth plus income, even as margin pressure and a USD 3.98 billion long-term debt load remain key risks that could limit multiple expansion.